Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Serum 25(OH)D3 concentration significantly decreased in the HFD-fed group.

Source: Stabilization of vitamin D level in the serum by grifolin and grifolic acid. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Sphingomyelin synthase inhibitors from edible mushrooms prevent overweight and improve vitamin D homeostasis in a mouse model of diet-induced obesity

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Sphingomyelin synthase inhibitors from edible mushrooms prevent overweight and improve vitamin D homeostasis in a mouse model of diet-induced obesity

Study design awaiting verification · Frontiers in Nutrition · 2025

Original publication title

Sphingomyelin synthase inhibitors from edible mushrooms prevent overweight and improve vitamin D homeostasis in a mouse model of diet-induced obesity

Enkhmaa Enkhbat; Yuta Murai; Kohei Yuyama; Hui Sun; Mahadeva M. M. Swamy; Yoshiko Suga; Masaki Anetai; Kenji Monde

Copyright © 2025 Enkhbat, Murai, Yuyama, Sun, Swamy, Suga, Anetai and Monde.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These findings demonstrate, for the first time, that mushroom-derived metabolites can act as dual-substrate SMS inhibitors with beneficial effects on lipid and vitamin D metabolism. Grifolin and grifolic acid thus represent promising candidates for development as functional food components or nutraceuticals to prevent obesity and metabolic syndrome.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Sphingomyelin synthase (SMS) is a key enzyme in sphingolipid metabolism that converts phosphatidylcholine and ceramide into sphingomyelin and diacylglycerol, thereby influencing lipid signaling and metabolic regulation. Identifying natural SMS inhibitors is of interest for the prevention and management of obesity and related disorders.

Source: Introduction

Abstract: What methods does the paper describe?

We screened more than 860 extracts from medicinal plants and mushrooms using a cell-based assay for SMS inhibition. Active fractions were purified, and grifolin and grifolic acid were isolated from the edible mushroom Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouzar and structurally confirmed. Their inhibitory activity was validated in vitro against sphingomyelin synthase 1 (SMS1) and sphingomyelin synthase 2 (SMS2), and their metabolic effects were tested by dietary supplementation (0.1% in high-fat diet) in male C57BL/6J mice for 9 weeks.

Source: Methods

Abstract: Results

Both compounds inhibited SMS activity at low micromolar concentrations. In vivo, they significantly reduced body weight gain, improved glucose tolerance, and alleviated hepatic steatosis in high-fat diet: fed mice. Treatment also preserved circulating 25-hydroxyvitamin D₃ [25(OH)D₃] concentrations and downregulated hepatic expression of the vitamin D: catabolizing enzyme CYP24A1.

Source: Results

Abstract: Conclusion

These findings demonstrate, for the first time, that mushroom-derived metabolites can act as dual-substrate SMS inhibitors with beneficial effects on lipid and vitamin D metabolism. Grifolin and grifolic acid thus represent promising candidates for development as functional food components or nutraceuticals to prevent obesity and metabolic syndrome.

Source: Conclusion
Authors’ abstract

Introduction

Sphingomyelin synthase (SMS) is a key enzyme in sphingolipid metabolism that converts phosphatidylcholine and ceramide into sphingomyelin and diacylglycerol, thereby influencing lipid signaling and metabolic regulation. Identifying natural SMS inhibitors is of interest for the prevention and management of obesity and related disorders.

Methods

We screened more than 860 extracts from medicinal plants and mushrooms using a cell-based assay for SMS inhibition. Active fractions were purified, and grifolin and grifolic acid were isolated from the edible mushroom Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouzar and structurally confirmed. Their inhibitory activity was validated in vitro against sphingomyelin synthase 1 (SMS1) and sphingomyelin synthase 2 (SMS2), and their metabolic effects were tested by dietary supplementation (0.1% in high-fat diet) in male C57BL/6J mice for 9 weeks.

Results

Both compounds inhibited SMS activity at low micromolar concentrations. In vivo, they significantly reduced body weight gain, improved glucose tolerance, and alleviated hepatic steatosis in high-fat diet: fed mice. Treatment also preserved circulating 25-hydroxyvitamin D₃ [25(OH)D₃] concentrations and downregulated hepatic expression of the vitamin D: catabolizing enzyme CYP24A1.

Conclusion

These findings demonstrate, for the first time, that mushroom-derived metabolites can act as dual-substrate SMS inhibitors with beneficial effects on lipid and vitamin D metabolism. Grifolin and grifolic acid thus represent promising candidates for development as functional food components or nutraceuticals to prevent obesity and metabolic syndrome.

Publication and source details

Original title: Sphingomyelin synthase inhibitors from edible mushrooms prevent overweight and improve vitamin D homeostasis in a mouse model of diet-induced obesity

Enkhmaa Enkhbat; Yuta Murai; Kohei Yuyama; Hui Sun; Mahadeva M. M. Swamy; Yoshiko Suga; Masaki Anetai; Kenji Monde

Frontiers in Nutrition · 2025

* Correspondence: Kenji Monde, kmonde@sci.hokudai.ac.jpCopyright © 2025 Enkhbat, Murai, Yuyama, Sun, Swamy, Suga, Anetai and Monde.2025Enkhbat, Murai, Yuyama, Sun, Swamy, Suga, Anetai and Mondehttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Hokkaido University10.13039/501100005946 JPJS00420230001The author(s) declare that financial support was received for the research and/or publication of this article. This work was partially supported by a grant-in-aid for scientific research KAKENHI (grants 23K24187, 24K21815 for KM, 24K08626 for YM, 23K13851 for MMMS) from the MEXT of Japan, JSPS J-PEAKS (JPJS00420230001), and the Photo-excitonix Project in Hokkaido University. This work was inspired by the JSPS Asian CORE Program “Asian Chemical Biology Initiative” Program. EE thanks the International Graduate Program (IGP), Hokkaido University, for the scholarship given.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:38:42.929904+00:00

DOI: 10.3389/fnut.2025.1658130 · PMC12728570